Is aspirin 300mg indicated for ischemic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aspirin 300mg in Acute Ischemic Stroke Management

Aspirin 300mg is indicated for acute ischemic stroke within 24-48 hours of symptom onset, provided there are no contraindications and the patient is not receiving thrombolytic therapy. 1

Evidence-Based Recommendations

Timing and Dosing

  • Aspirin should be administered within 24-48 hours after stroke onset 1
  • Dosage range of 160-300mg is supported by high-quality evidence 1
  • The 300mg dose specifically was evaluated in the International Stroke Trial and showed benefit 1

Clinical Benefits

  • Reduces risk of early recurrent ischemic stroke 1, 2
  • Decreases mortality and dependency at follow-up 2
  • For every 1000 patients treated with aspirin:
    • 13 more patients will be alive and independent at follow-up 2
    • 10 more patients will make a complete recovery 3
    • 7 fewer recurrent ischemic strokes will occur 3

Important Precautions

  • Aspirin should NOT be used as a substitute for thrombolytic therapy in eligible patients 1
  • Administration should be delayed until 24 hours after IV alteplase (thrombolysis) 1
  • Brain imaging must be performed before administration to exclude intracranial hemorrhage 1

Administration Considerations

Route of Administration

  • Oral administration is preferred if the patient can swallow safely
  • For patients with dysphagia:
    • Rectal administration (suppository) is appropriate 1, 4
    • Nasogastric tube administration is an option 2

Bleeding Risk

  • Small but significant increase in risk of:
    • Symptomatic intracranial hemorrhage (approximately 2 per 1000 patients treated) 3
    • Systemic hemorrhage 1
  • This risk is outweighed by the benefits in reduction of recurrent stroke and improved outcomes 2, 3

Algorithm for Decision-Making

  1. Confirm ischemic stroke diagnosis with brain imaging
  2. Determine if patient is eligible for thrombolysis:
    • If YES: Administer thrombolysis first, then start aspirin after 24 hours
    • If NO: Proceed to step 3
  3. Check for contraindications to aspirin:
    • Active bleeding
    • Known aspirin allergy
    • Recent gastrointestinal bleeding
  4. If no contraindications, administer aspirin 300mg:
    • Within 24-48 hours of symptom onset
    • Choose appropriate route based on swallowing ability

Special Considerations

  • The benefit of aspirin appears primarily related to prevention of early recurrent events rather than limiting neurological consequences of the initial stroke 1
  • While some guidelines have moved away from specifying the exact dose, the evidence specifically supports doses between 160-300mg 1
  • The 2018 AHA/ASA guidelines removed the specific 325mg dosing recommendation that was in previous guidelines, acknowledging that clinical trials supporting aspirin use included doses of 160-300mg 1

Aspirin 300mg represents a well-established, evidence-based intervention that provides a modest but significant benefit in reducing mortality and disability following acute ischemic stroke.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral antiplatelet therapy for acute ischaemic stroke.

The Cochrane database of systematic reviews, 2022

Research

Antiplatelet therapy for acute ischaemic stroke.

The Cochrane database of systematic reviews, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.